全文获取类型
收费全文 | 1800篇 |
免费 | 110篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 80篇 |
妇产科学 | 31篇 |
基础医学 | 300篇 |
口腔科学 | 54篇 |
临床医学 | 115篇 |
内科学 | 443篇 |
皮肤病学 | 13篇 |
神经病学 | 77篇 |
特种医学 | 139篇 |
外科学 | 140篇 |
综合类 | 10篇 |
预防医学 | 101篇 |
眼科学 | 7篇 |
药学 | 170篇 |
中国医学 | 4篇 |
肿瘤学 | 240篇 |
出版年
2023年 | 8篇 |
2022年 | 12篇 |
2021年 | 18篇 |
2020年 | 8篇 |
2019年 | 37篇 |
2018年 | 32篇 |
2017年 | 32篇 |
2016年 | 29篇 |
2015年 | 36篇 |
2014年 | 42篇 |
2013年 | 62篇 |
2012年 | 74篇 |
2011年 | 74篇 |
2010年 | 57篇 |
2009年 | 76篇 |
2008年 | 79篇 |
2007年 | 92篇 |
2006年 | 69篇 |
2005年 | 76篇 |
2004年 | 84篇 |
2003年 | 56篇 |
2002年 | 59篇 |
2001年 | 37篇 |
2000年 | 60篇 |
1999年 | 36篇 |
1998年 | 47篇 |
1997年 | 38篇 |
1996年 | 37篇 |
1995年 | 39篇 |
1994年 | 37篇 |
1993年 | 33篇 |
1992年 | 43篇 |
1991年 | 27篇 |
1990年 | 35篇 |
1989年 | 44篇 |
1988年 | 39篇 |
1987年 | 28篇 |
1986年 | 44篇 |
1985年 | 21篇 |
1984年 | 23篇 |
1983年 | 13篇 |
1982年 | 20篇 |
1981年 | 10篇 |
1980年 | 16篇 |
1979年 | 13篇 |
1978年 | 12篇 |
1975年 | 14篇 |
1974年 | 6篇 |
1973年 | 6篇 |
1969年 | 8篇 |
排序方式: 共有1933条查询结果,搜索用时 15 毫秒
51.
Ettore Porreca Concetta Di Febbo Assunta Pandolfi Andria D''Orazio Nicola Martelli Andrea Mezzetti Franco Cuccurullo Andreina Poggi 《Atherosclerosis》1993,100(2):141-148
We studied the relation between the glutathione (GSH) system and cell proliferation in a model of smooth muscle cells (SMC) derived from the thoracic aorta of 4–6-week-old (young) and 15-month-old (aged) rats. SMC from aged rats showed greater levels of total non-protein thiol compounds (T-SH), increased glutathione transferase (GST) and increased glutathione reductase (GSSG-Red) activities compared with cells from young rats. These changes were associated with an increased proliferation rate of SMC from aged rats. To evaluate the role of GSH on cell proliferation better, a specific inhibitor of gamma-glutamyl-cystein synthetase,
-buthionine-SR-sulphoximine (BSO) was used. BSO showed a dose-dependent inhibition of cell growth, with an IC50 of 10−4 M, after 48–72 h of incubation. Removal of BSO restored cell growth, further suggesting a link between GSH levels and vascular cell proliferation. The inhibitory effect of BSO was about two times greater on SMC from young than on SMC from aged rats. BSO showed 56% inhibition on the proliferation of SMC from young rats and 32% inhibition on SMC from aged rats (10−4 M, 72 h of incubation). A parallel reduction of GSH levels of 38% and 19% for SMC from young and aged rats, respectively, was observed, suggesting that age-related factors may influence the involvement of GSH system in cell proliferation. 相似文献
52.
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens 总被引:2,自引:0,他引:2
B. Falini S. Venturi M. Martelli A. Santucci S. Pileri E. Pescarmona M. Giovannini P. Mazza M. F. Martelli L. Pasqualucci E. Ballatori C. Guglielmi S. Amadori S. Poggi E. Sabattini F. Gherlinzoni P. L. Zinzani C. D. Baroni F. Mandelli S. Tura 《British journal of haematology》1995,89(4):780-789
We report on the immunophenotype, clinical findings and response to aggressive chemotherapy of 18 patients with mediastinal large B-cell lymphoma (MLCL). Cases were collected from a series of 286 high-grade non-Hodgkin's lymphomas (HG-NHL) which, in the period September 1988 to August 1991, were enrolled in a prospective multicentre trial designed to compare the MACOP-B and F-MACHOP regimens. Immunostaining on frozen sections revealed a previously unrecognized phenotype, i.e. co-expression of B-cell (CD19, CD20, CD22, Ig-associated dimer) and activation-associated antigens (CD30 and CDw70) in about 60% of MLCL cases; in contrast, the activation-associated antigens CD25 and Ki-27 (unclustered) were consistently negative. This peculiar phenotype may reflect a derivation of the tumour from a subset of thymic activated B cells. Clinically, the patients (median age 31 years; F/M ratio 2.6) presented with bulky mediastinal mass (72%) associated with mediastinal syndrome in >50% cases; disease was stage IIA in most cases. All 18 patients received aggressive chemotherapy (F-MACHOP 11; MACOP-B 7). Complete response (CR) was achieved in 57.1% of cases treated with MACOP-B. In contrast, the response of the 11 MLCL treated with F-MACHOP was poor (CR 18.2%) as compared to that of the 135 HG-NHL treated with the same regimen during the trial (CR 69.6%). This difference was still statistically significant after adjusting for negative prognostic factors (mediastinal mass > 10 cm plus increased LDH) and suggests that F-MACHOP might not be the most appropriate regimen for this kind of lymphoma. 相似文献
53.
54.
Marc H. V. Van Regenmortel Hans-Wolfgang Ackermann Charles H. Calisher Ralf G. Dietzgen Marian C. Horzinek Gunther M. Keil Brian W. J. Mahy Giovanni P. Martelli Frederick A. Murphy Craig Pringle Bert K. Rima Tim Skern H.-J. Vetten Scott C. Weaver 《Archives of virology》2013,158(5):1115-1119
The Executive Committee of the International Committee on Taxonomy of Viruses (ICTV) has recently decided to modify the current definition of virus species (Code of Virus Classification and Nomenclature Rule 3.21) and will soon ask the full ICTV membership (189 voting members) to ratify the proposed controversial change. In this discussion paper, 14 senior virologists, including six Life members of the ICTV, compare the present and proposed new definition and recommend that the existing definition of virus species should be retained. Since the pros and cons of the proposal posted on the ICTV website are not widely consulted, the arguments are summarized here in order to reach a wider audience. 相似文献
55.
56.
F Mandelli M Martelli G Cimino G Alimena A P Anselmo M R De Cuia R Gastaldi W Arcese G Papa 《Scandinavian journal of haematology》1985,34(2):97-100
We report the case of a 38-year-old man, previously treated for Hodgkin's disease (HD) with chemo-radiotherapy who, 10 years later, developed a Burkitt lymphoma (BL) as a tumour mass of the ascendent colon and regional lymph nodes and, subsequently, on leukaemic bone-marrow cells, on the basis of histological, immunological (B phenotype, IgM-lambda) and cytogenetic, translocation t(8;14) features. The patient died a few days later; at autopsy no evidence of HD was found. This is the 2nd case of BL developing after HD so far described. The relationship between the 2 diseases is discussed and the importance of the immunodepression in the pathogenesis of the secondary Burkitt lymphoma is emphasized. 相似文献
57.
Allergen Component Specific IgE Measurement With the Immulite™ 2000 System: Diagnostic Accuracy and Intermethod Comparison 下载免费PDF全文
58.
L. Testai S. Rapposelli A. Martelli M.C. Breschi V. Calderone 《Medicinal research reviews》2015,35(3):520-553
Brief periods of ischemia are known to confer to the myocardium an increased resistance to the injury due to a later and more prolonged ischemic episode. This phenomenon, known as ischemic preconditioning (IPreC), is ensured by different biological mechanisms. Although an exhaustive comprehension of them has not been reached yet, it is widely accepted that mitochondria are pivotally involved in controlling cell life and death, and thus in IPreC. Among the several signaling pathways involved, as triggers and/or end effectors, in the mitochondrial mechanisms of cardioprotection, an important role is played by the activation of potassium channels located in the mitochondrial inner membrane (mitoK) of cardiomyocytes. Presently, different types of mitoK channels have been recognized in the heart, such as ATP‐sensitive (mitoKATP) and calcium‐activated (mitoBKCa and mitoSKCa) potassium channels. Consistently, drugs modulating mitoK, on one hand, have been employed as useful experimental tools for early basic studies on IPreC. On the other hand, activators of mitoK are promising and innovative therapeutic agents for limiting the myocardial injury due to ischemic episodes. In this review, we report the experimental evidence supporting the role of mitoK in signaling pathways in the mechanisms of cardioprotection and an overview on the most important molecules acting as modulators of these channels, with their profiles of selectivity. Some innovative pharmaceutical strategies for mitochondriotropic drugs have been also reported. Finally, an appendix describing the main experimental approaches usually employed to study mitoK in isolated mitochondria or in intact cells has been added. 相似文献
59.